Corient Private Wealth’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
25,398
+331
+1% +$17K ﹤0.01% 1703
2026
Q1
$1.49M Sell
25,067
-217
-0.9% -$14.1K ﹤0.01% 1416
2025
Q4
$1.56M Sell
25,284
-609
-2% -$37.3K ﹤0.01% 1272
2025
Q3
$1.62M Buy
25,893
+5,499
+27% +$383K ﹤0.01% 1168
2025
Q2
$1.63M Buy
20,394
+762
+4% +$63.7K ﹤0.01% 1129
2025
Q1
$1.69M Buy
19,632
+4,469
+29% +$367K ﹤0.01% 1036
2024
Q4
$1.18M Buy
15,163
+11,650
+332% +$905K ﹤0.01% 1241
2024
Q3
$253K Sell
3,513
-113
-3% -$8K ﹤0.01% 2101
2024
Q2
$250K Buy
3,626
+110
+3% +$7.45K ﹤0.01% 2010
2024
Q1
$255K Buy
3,516
+59
+2% +$3.94K ﹤0.01% 1984
2023
Q4
$212K Sell
3,457
-424
-11% -$25.2K ﹤0.01% 2047
2023
Q3
$222K Buy
3,881
+138
+4% +$8.34K ﹤0.01% 1871
2023
Q2
$222K Buy
+3,743
New +$224K ﹤0.01% 1825

Other funds holding PBH

Corient Private Wealth's PBH Position: Q2 2026 in Review

Corient Private Wealth increased its Prestige Consumer Healthcare (PBH) stake by 1.3% in Q2 2026, buying an estimated $17K and bringing the position to 25,398 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

Corient Private Wealth first reported a position in PBH in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.69M in Q1 2025. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Corient Private Wealth held 25,398 shares of Prestige Consumer Healthcare worth $1.2M as of Q2 2026.
  • Corient Private Wealth bought 331 Prestige Consumer Healthcare shares in Q2 2026, an estimated $17K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1703 holding.
  • Corient Private Wealth first reported a position in Prestige Consumer Healthcare in Q2 2023 and has held it in 13 quarters since.
  • Corient Private Wealth's Prestige Consumer Healthcare position peaked at $1.69M in Q1 2025.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.